Physician profile
Warren Ervin
NPI 1780722587
$888.63
in general payments reported to CMS, 2019-2025
20 companies · $43.01 in 2025
The $43.01 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $256 · 2020: $286 · 2021: $145 · 2022: $113 · 2024: $45.98 · 2025: $43.01.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $88.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $88.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $124.24 | 2019-2022 | |
| Adlon Therapeutics L.P. | $83.40 | 2020-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $82.16 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $80.64 | 2020-2025 | Gardasil 9, Vaxneuvance, Rotateq |
| Kaleo, INC. | $79.03 | 2019-2021 | |
| Neos Therapeutics, LP | $71.70 | 2019-2021 | |
| Pfizer INC. | $60.18 | 2019-2020 | |
| Ironshore Pharmaceuticals INC. | $53.33 | 2019-2020 | |
| Corium, LLC | $36.21 | 2022 | |
| Cranial Technologies, INC | $28.29 | 2019-2021 | |
| Glaxosmithkline, LLC. | $27.22 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $22.81 | 2019 | |
| Verrica Pharmaceuticals INC. | $21.32 | 2024 | Ycanth |
| Astrazeneca Pharmaceuticals LP | $20.39 | 2022 | |
| Seqirus USA INC | $18.64 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $18.11 | 2025 | Id Now Instrument |
| Qiagen, LLC | $17.43 | 2020 | |
| Rhodes Pharmaceuticals L.P. | $16.56 | 2019 | |
| Arbor Pharmaceuticals, INC. | $13.54 | 2019 | |
| Abbvie INC. | $13.43 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Warren Ervin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.